Loading...
•
Sep 30, 2022
Myriad Genetics Q3 2022 Earnings Report
Myriad Genetics reported third quarter financial results.
Key Takeaways
Myriad Genetics' third quarter revenue was $156.4 million. GAAP EPS was $(0.43) and adjusted EPS was $(0.19). The company acquired Gateway Genomics, LLC for $67.5 million cash and up to an additional $32.5 million of cash consideration.
Revenue of $156.4 million for the quarter ended September 30, 2022.
Third quarter testing volumes, excluding divested businesses, grew 12% year-over-year.
Diluted GAAP earnings per share (EPS) were $(0.43) and adjusted EPS were $(0.19) in the third quarter of 2022.
Acquired Gateway Genomics, LLC, a leading private developer of consumer genetic tests serving the women’s health market for $67.5 million cash and up to an additional $32.5 million of cash consideration.
Revenue by Segment
Forward Guidance
Myriad Genetics updated full year 2022 financial guidance to reflect third quarter business updates.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...